1. Home
  2. ITOS vs FRA Comparison

ITOS vs FRA Comparison

Compare ITOS & FRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • FRA
  • Stock Information
  • Founded
  • ITOS 2011
  • FRA 2003
  • Country
  • ITOS United States
  • FRA United States
  • Employees
  • ITOS N/A
  • FRA N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • FRA Investment Bankers/Brokers/Service
  • Sector
  • ITOS Health Care
  • FRA Finance
  • Exchange
  • ITOS Nasdaq
  • FRA Nasdaq
  • Market Cap
  • ITOS 381.2M
  • FRA 449.1M
  • IPO Year
  • ITOS 2020
  • FRA N/A
  • Fundamental
  • Price
  • ITOS $10.18
  • FRA $13.25
  • Analyst Decision
  • ITOS Hold
  • FRA
  • Analyst Count
  • ITOS 6
  • FRA 0
  • Target Price
  • ITOS $10.60
  • FRA N/A
  • AVG Volume (30 Days)
  • ITOS 911.6K
  • FRA 165.4K
  • Earning Date
  • ITOS 08-07-2025
  • FRA 01-01-0001
  • Dividend Yield
  • ITOS N/A
  • FRA 11.06%
  • EPS Growth
  • ITOS N/A
  • FRA N/A
  • EPS
  • ITOS N/A
  • FRA N/A
  • Revenue
  • ITOS $35,000,000.00
  • FRA N/A
  • Revenue This Year
  • ITOS N/A
  • FRA N/A
  • Revenue Next Year
  • ITOS N/A
  • FRA N/A
  • P/E Ratio
  • ITOS N/A
  • FRA N/A
  • Revenue Growth
  • ITOS 177.89
  • FRA N/A
  • 52 Week Low
  • ITOS $4.80
  • FRA $11.33
  • 52 Week High
  • ITOS $18.13
  • FRA $13.10
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 67.57
  • FRA 71.21
  • Support Level
  • ITOS $9.95
  • FRA $12.85
  • Resistance Level
  • ITOS $10.20
  • FRA $12.96
  • Average True Range (ATR)
  • ITOS 0.15
  • FRA 0.10
  • MACD
  • ITOS -0.09
  • FRA 0.03
  • Stochastic Oscillator
  • ITOS 90.00
  • FRA 84.91

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About FRA Blackrock Floating Rate Income Strategies Fund Inc

Blackrock Floating Rate Inc Stra Fd Inc is a United States-based diversified closed-ended management investment company. The Fund's investment objective is to provide shareholders with high current income and preservation of capital with investment in a diversified, leveraged portfolio consisting of floating-rate debt securities and instruments.

Share on Social Networks: